Yuguang Wang

Person

North Brunswick, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bicyclic and tricyclic derivatives as thrombin receptor antagonists
- Patent number 8,153,664
- Issue date Apr 10, 2012
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cannabinoid receptor modulators
- Patent number 7,897,601
- Issue date Mar 1, 2011
- Intervet, Inc.
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxazoloisoquinoline derivatives as thrombin receptor antagonists
- Patent number 7,888,369
- Issue date Feb 15, 2011
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thrombin receptor antagonists
- Patent number 7,713,999
- Issue date May 11, 2010
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Xanthine phosphodiesterase V inhibitors
- Patent number 7,531,544
- Issue date May 12, 2009
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Constrained himbacine analogs as thrombin receptor antagonists
- Patent number 7,442,712
- Issue date Oct 28, 2008
- Schering Corporation
- Mariappan V. Chelliah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thrombin receptor antagonists
- Patent number 7,304,078
- Issue date Dec 4, 2007
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Xanthine phosphodiesterase V inhibitors
- Patent number 7,268,141
- Issue date Sep 11, 2007
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polycyclic guanine phosphodiesterase V inhibitors
- Patent number 6,969,719
- Issue date Nov 29, 2005
- Schering Corporation
- Theodros Asberom
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Muscarinic antagonists
- Patent number 6,831,089
- Issue date Dec 14, 2004
- Schering Corporation
- Yuguang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Xanthine phosphodiesterase V inhibitors
- Patent number 6,821,978
- Issue date Nov 23, 2004
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Muscarinic antagonists
- Patent number 6,498,168
- Issue date Dec 24, 2002
- Schering Corporation
- Derek Lowe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Muscarinic antagonists
- Patent number 6,288,068
- Issue date Sep 11, 2001
- Schering Corporation
- Derek Lowe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Muscarinic antagonists
- Patent number 6,043,255
- Issue date Mar 28, 2000
- Schering Corporation
- Derek B. Lowe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Muscarinic antagonists
- Patent number 6,037,352
- Issue date Mar 14, 2000
- Schering Corporation
- Derek Lowe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ether muscarinic antagonists
- Patent number 5,977,138
- Issue date Nov 2, 1999
- Schering Corporation
- Yuguang Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Muscarinic antagonists
- Patent number 5,889,006
- Issue date Mar 30, 1999
- Schering Corporation
- Derek B. Lowe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Muscarinic antagonists
- Patent number 5,883,096
- Issue date Mar 16, 1999
- Schering Corporation
- Derek Lowe
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
BICYCLIC AND TRICYCLIC DERIVATIVES AS THROMBIN RECEPTOR ANTAGONISTS
- Publication number 20120157403
- Publication date Jun 21, 2012
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic And Tricyclic Derivatives As Thrombin Receptor Antagonists
- Publication number 20080090830
- Publication date Apr 17, 2008
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thrombin Receptor Antagonists Based On The Modified Tricyclic Unit...
- Publication number 20080085923
- Publication date Apr 10, 2008
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Xanthine Phosphodiesterase V Inhibitors
- Publication number 20080058354
- Publication date Mar 6, 2008
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THROMBIN RECEPTOR ANTAGONISTS
- Publication number 20070270439
- Publication date Nov 22, 2007
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CANNABINOID RECEPTOR MODULATORS
- Publication number 20070254952
- Publication date Nov 1, 2007
- Yuguang Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cannabinoid receptor modulators
- Publication number 20070197628
- Publication date Aug 23, 2007
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THROMBIN RECEPTOR ANTAGONISTS
- Publication number 20070179187
- Publication date Aug 2, 2007
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Oxazoloisoquinoline derivatives as thrombin receptor antagonists
- Publication number 20070149518
- Publication date Jun 28, 2007
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Constrained himbacine analogs as thrombin receptor antagonists
- Publication number 20050267155
- Publication date Dec 1, 2005
- Mariappan V. Chelliah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Xanthine phosphodiesterase V inhibitors
- Publication number 20050182077
- Publication date Aug 18, 2005
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Xanthine phosphodiesterase V inhibitors
- Publication number 20050075349
- Publication date Apr 7, 2005
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Xanthine phosphodiesterase V inhibitors
- Publication number 20040229885
- Publication date Nov 18, 2004
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Xanthine phosphodiesterase V inhibitors
- Publication number 20040167137
- Publication date Aug 26, 2004
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thrombin receptor antagonists
- Publication number 20030216437
- Publication date Nov 20, 2003
- Schering Corporation
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Muscarinic antagonists
- Publication number 20030207917
- Publication date Nov 6, 2003
- Schering Corporation
- Yuguang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Polycyclic guanine phosphodiesterase V inhibitors
- Publication number 20030153587
- Publication date Aug 14, 2003
- Schering Corporation
- Theodros Asberom
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Xanthine phosphodiesterase V inhibitors
- Publication number 20020169174
- Publication date Nov 14, 2002
- Samuel Chackalamannil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Muscarinic antagonists
- Publication number 20020103205
- Publication date Aug 1, 2002
- Derek Lowe
- C07 - ORGANIC CHEMISTRY

Yuguang Wang

Person

Patents Grantslast 30 patents

Bicyclic and tricyclic derivatives as thrombin receptor antagonists

Cannabinoid receptor modulators

Oxazoloisoquinoline derivatives as thrombin receptor antagonists

Thrombin receptor antagonists

Xanthine phosphodiesterase V inhibitors

Constrained himbacine analogs as thrombin receptor antagonists

Thrombin receptor antagonists

Xanthine phosphodiesterase V inhibitors

Polycyclic guanine phosphodiesterase V inhibitors

Muscarinic antagonists

Xanthine phosphodiesterase V inhibitors

Muscarinic antagonists

Muscarinic antagonists

Muscarinic antagonists

Muscarinic antagonists

Ether muscarinic antagonists

Muscarinic antagonists

Muscarinic antagonists

Patents Applicationslast 30 patents

BICYCLIC AND TRICYCLIC DERIVATIVES AS THROMBIN RECEPTOR ANTAGONISTS

Bicyclic And Tricyclic Derivatives As Thrombin Receptor Antagonists

Thrombin Receptor Antagonists Based On The Modified Tricyclic Unit...

Xanthine Phosphodiesterase V Inhibitors

THROMBIN RECEPTOR ANTAGONISTS

CANNABINOID RECEPTOR MODULATORS

Cannabinoid receptor modulators

THROMBIN RECEPTOR ANTAGONISTS

Oxazoloisoquinoline derivatives as thrombin receptor antagonists

Constrained himbacine analogs as thrombin receptor antagonists

Xanthine phosphodiesterase V inhibitors

Xanthine phosphodiesterase V inhibitors

Xanthine phosphodiesterase V inhibitors

Xanthine phosphodiesterase V inhibitors

Thrombin receptor antagonists

Muscarinic antagonists

Polycyclic guanine phosphodiesterase V inhibitors

Xanthine phosphodiesterase V inhibitors

Muscarinic antagonists